• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans.氟喹诺酮类药物：人体药理学、临床应用及毒性
Antimicrob Agents Chemother. 1985 Nov;28(5):716-21. doi: 10.1128/AAC.28.5.716.
2
[Fluoroquinolones].[氟喹诺酮类]
Mikrobiyol Bul. 1987 Apr;21(2):151-7.
3
In vitro susceptibility of aerobic gram-negative blood culture isolates to oxolinic acid, norfloxacin, ciprofloxacin, enoxacin, pefloxacin, ofloxacin and oxo-enoxacin.需氧革兰氏阴性血培养分离株对恶喹酸、诺氟沙星、环丙沙星、依诺沙星、培氟沙星、氧氟沙星和氧恶喹酸的体外敏感性
Infection. 1986 May-Jun;14(3):142-4. doi: 10.1007/BF01643481.
4
Comparative in vitro activity of amifloxacin and five other fluoroquinolone antimicrobial agents and preliminary criteria for the disk susceptibility test.阿米氟沙星与其他五种氟喹诺酮类抗菌剂的体外活性比较及纸片药敏试验的初步标准。
Eur J Clin Microbiol. 1987 Apr;6(2):179-82. doi: 10.1007/BF02018204.
5
Clinical use of the quinolones.喹诺酮类药物的临床应用。
Lancet. 1987 Dec 5;2(8571):1319-22. doi: 10.1016/s0140-6736(87)91205-0.
6
Clinical uses of nalidixic acid analogues: the fluoroquinolones.萘啶酸类似物的临床应用：氟喹诺酮类药物。
Eur J Clin Microbiol. 1986 Apr;5(2):138-40. doi: 10.1007/BF02013968.
7
The adverse effects of fluoroquinolones.
J Antimicrob Chemother. 1987 Jun;19(6):709-11. doi: 10.1093/jac/19.6.709.
8
Comparative in vitro activity of seven quinolones against 100 clinical isolates of Clostridium difficile.七种喹诺酮类药物对100株艰难梭菌临床分离株的体外活性比较
Antimicrob Agents Chemother. 1986 Feb;29(2):374-5. doi: 10.1128/AAC.29.2.374.
9
Comparative in vitro activities of ciprofloxacin, enoxacin, norfloxacin, ofloxacin and pefloxacin against Bacteroides fragilis and Clostridium difficile.环丙沙星、依诺沙星、诺氟沙星、氧氟沙星和培氟沙星对脆弱拟杆菌和艰难梭菌的体外活性比较
Scand J Infect Dis. 1986;18(2):149-51. doi: 10.3109/00365548609032321.
10
In vitro activity, pharmacokinetics, clinical safety and therapeutic efficacy of enoxacin in the treatment of patients with complicated urinary tract infections.依诺沙星治疗复杂性尿路感染患者的体外活性、药代动力学、临床安全性及治疗效果
Infection. 1985 Sep-Oct;13(5):219-24. doi: 10.1007/BF01667215.

引用本文的文献

1
Advances in the Synthesis and Biological Applications of Enoxacin-Based Compounds.依诺沙星类化合物的合成及生物应用进展。
Biomolecules. 2024 Nov 7;14(11):1419. doi: 10.3390/biom14111419.
2
Comparative Evaluation of L-PRF and Ofloxacin Incorporated L-PRF as an Adjunctive to SRP-A Split-Mouth Randomized Clinical Trial.L-PRF与含左氧氟沙星的L-PRF作为龈下刮治术辅助治疗的比较评价：一项分口随机临床试验
J Pharm Bioallied Sci. 2024 Apr;16(Suppl 2):S1369-S1372. doi: 10.4103/jpbs.jpbs_382_23. Epub 2024 Apr 16.
3
sequence type 410 with carbapenemases: a paradigm shift within toward multidrug resistance.携带碳青霉烯酶的 410 型序列：对 多药耐药性的范式转变。
Antimicrob Agents Chemother. 2024 Feb 7;68(2):e0133923. doi: 10.1128/aac.01339-23. Epub 2024 Jan 9.
4
Draft Genome Sequences of 14 Fluoroquinolone-Resistant Escherichia coli Isolates from Imported Shrimp.14株源自进口虾的耐氟喹诺酮类大肠杆菌分离株的基因组序列草图
Microbiol Resour Announc. 2023 Apr 18;12(4):e0111622. doi: 10.1128/mra.01116-22. Epub 2023 Mar 1.
5
Chemical Aspects of Human and Environmental Overload with Fluorine.氟化物对人类和环境的超负荷影响的化学方面。
Chem Rev. 2021 Apr 28;121(8):4678-4742. doi: 10.1021/acs.chemrev.0c01263. Epub 2021 Mar 16.
6
Expression of the qepA1 gene is induced under antibiotic exposure.qepA1 基因的表达在抗生素暴露下被诱导。
J Antimicrob Chemother. 2021 May 12;76(6):1433-1440. doi: 10.1093/jac/dkab045.
7
Fluoroquinolone Antibiotics Exhibit Low Antiviral Activity against SARS-CoV-2 and MERS-CoV.氟喹诺酮类抗生素对 SARS-CoV-2 和 MERS-CoV 表现出低抗病毒活性。
Viruses. 2020 Dec 23;13(1):8. doi: 10.3390/v13010008.
8
Resistance/fitness trade-off is a barrier to the evolution of MarR inactivation mutants in Escherichia coli.抗性/适应度权衡是大肠杆菌 MarR 失活突变体进化的障碍。
J Antimicrob Chemother. 2021 Jan 1;76(1):77-83. doi: 10.1093/jac/dkaa417.
9
Fluorometric determination for ofloxacin by using an aptamer and SYBR Green I.基于适配体和 SYBR Green I 的荧光法测定氧氟沙星
Mikrochim Acta. 2019 Sep 5;186(10):668. doi: 10.1007/s00604-019-3788-8.
10
Characterizing Shigella species distribution and antimicrobial susceptibility to ciprofloxacin and nalidixic acid in Latin America between 2000-2015.描述 2000-2015 年拉丁美洲志贺菌属种的分布特征以及对环丙沙星和萘啶酸的药敏性。
PLoS One. 2019 Aug 2;14(8):e0220445. doi: 10.1371/journal.pone.0220445. eCollection 2019.

本文引用的文献

1
Urinary tract antiseptics.尿路抗菌药。
Med Clin North Am. 1982 Jan;66(1):199-208. doi: 10.1016/s0025-7125(16)31453-5.
2
Treatment of uncomplicated gonorrhea with rosoxacin.用罗索沙星治疗单纯性淋病。
Antimicrob Agents Chemother. 1981 Nov;20(5):625-9. doi: 10.1128/AAC.20.5.625.
3
Pharmacokinetics and tissue penetration of ciprofloxacin.环丙沙星的药代动力学及组织穿透性
Antimicrob Agents Chemother. 1983 Nov;24(5):784-6. doi: 10.1128/AAC.24.5.784.
4
The pharmacokinetics and tissue penetration of ofloxacin.氧氟沙星的药代动力学和组织穿透性。 （注：原文中多了一个of，正确表述应该是The pharmacokinetics and tissue penetration of ofloxacin ）
J Antimicrob Chemother. 1984 Dec;14(6):647-52. doi: 10.1093/jac/14.6.647.
5
Penetration of pefloxacin into cerebrospinal fluid of patients with meningitis.培氟沙星在脑膜炎患者脑脊液中的穿透情况。
Antimicrob Agents Chemother. 1984 Sep;26(3):289-91. doi: 10.1128/AAC.26.3.289.
6
Dose-dependent pharmacokinetic study of pefloxacin, a new antibacterial agent, in humans.新型抗菌药物培氟沙星在人体的剂量依赖性药代动力学研究。
J Pharm Sci. 1984 Oct;73(10):1379-82. doi: 10.1002/jps.2600731014.
7
Serum and sputum concentrations of enoxacin after single oral dosing in a clinical and bacteriological study.在一项临床和细菌学研究中单次口服给药后依诺沙星的血清和痰液浓度。
J Antimicrob Chemother. 1984 Sep;14 Suppl C:83-9. doi: 10.1093/jac/14.suppl_c.83.
8
Pharmacokinetics and tissue penetration of enoxacin.依诺沙星的药代动力学和组织穿透性。
Antimicrob Agents Chemother. 1984 Jul;26(1):17-9. doi: 10.1128/AAC.26.1.17.
9
Absorption, distribution, metabolic fate, and elimination of pefloxacin mesylate in mice, rats, dogs, monkeys, and humans.甲磺酸培氟沙星在小鼠、大鼠、犬、猴及人体内的吸收、分布、代谢转归及消除
Antimicrob Agents Chemother. 1984 Apr;25(4):463-72. doi: 10.1128/AAC.25.4.463.
10
In-vitro activity of enoxacin (CL-919), a new quinoline derivative, compared with that of other antimicrobial agents.新喹啉衍生物依诺沙星（CL-919）的体外活性与其他抗菌剂的比较。
J Antimicrob Chemother. 1984 Mar;13(3):237-44. doi: 10.1093/jac/13.3.237.

The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans.

作者信息

Hooper D C, Wolfson J S

出版信息

Antimicrob Agents Chemother. 1985 Nov;28(5):716-21. doi: 10.1128/AAC.28.5.716.

DOI:10.1128/AAC.28.5.716
PMID:2936302
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC176369/
Abstract
摘要